Menopausal Hot Flashes Market - Global Industry Analysis

Menopausal Hot Flashes Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2026

Category: Healthcare Report Format : PDF Report Code: ZMR-6180 Status : Upcoming

Description

Global Menopausal Hot Flashes Market: Overview

The sudden sensation of heat, sweating, and flushed red face is the menopause hot flash. It happens when the blood vessels nearby the face widen to cool off, which also makes you sweat. It also boosts the heart rate of the human body. Smoking cigarettes, spicy foods, alcohol, caffeine, and stress triggers the menopause hot flashes.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Global Menopausal Hot Flashes Market: Growth Factors

One of the major factors driving the growth of the global menopausal hot flashes market is the growing need for treatment for menopause symptoms as women are increasingly facing disturbed mental and physical health. Moreover, a significant spike in insomnia, irritability, mood swings, fatigue, anxiety, migraine, formication, and hot flashes is also propelling the demand for menopause symptom medication. Women are facing a stressful and hectic lifestyle with no scope of relaxation and peace of mind. Moreover, the lack of sleep is also worsening the menopause symptoms. Such scenarios are propelling the growth of the global menopausal hot flashes market. Apart from medication, the prominent market players are recommending women to adopt edge-cutting technological devices that are made to lower the menopause symptoms as they perfectly fit the needs of women. Also, the emergence of smartwatch-like devices has also helped women like a personal thermostat. However, the significant spike in the adoption of cognitive behavior therapies to address the menopausal hot flash issues also drives the growth of the market globally. The growing demand for non-pharmacological treatment is likely to propel the growth of such therapies in the global menopausal hot flashes market. Healthcare professionals are offering cognitive behavior therapy to lower menopausal symptoms. However, the therapy is widely used due to the associated advantages of modifying the dysfunctional and emotional behavior that helps women to cope with the ongoing sufferings of anxiety and depression. The emergence of such therapies is likely to create long-term lucrative opportunities in the global menopausal hot flashes market. However, the growing awareness among women regarding menopausal hot flashes will further drive the growth of the global menopausal hot flashes market significantly during the forecast period. Also, the availability of a large number of treatment options other than oral medications has also boosted the growth of the global menopausal hot flashes market.

Global Menopausal Hot Flashes Market: Segmentation

The global menopausal hot flashes market can be segmented into treatment, distribution channel, and region.

By treatment, the market can be segmented into alternative, non-hormonal, and hormonal treatment. The hormonal treatment type accounts for the largest share in the global menopausal hot flashes market due to the adoption of prescribed medication to overcome hot flashes symptoms and vaginal dryness by the majority of women. The hormonal treatment segment can further be bifurcated into the estrogen-progesterone combination, progesterone, and estrogen. The non-hormonal segment can further be bifurcated into clonidine, pregabalin, gabapentin, and antidepressant. However, the alternative segment is also anticipated to witness huge growth during the forecast period. The alternative segment can further be bifurcated into herbal medicine, vitamin E, black cohosh, and others.

By distribution channel, the market can be segmented into online pharmacies, retail pharmacies, and hospital pharmacies. The hospital pharmacies segment holds the largest share in the global menopausal hot flashes market as a large number of women opt to get admitted to hospitals for better treatment owing to the presence of advanced technology and facilities in healthcare centers.

Global Menopausal Hot Flashes Market: Regional analysis

North America accounts for the largest share in the global menopausal hot flashes market due to the growing incidences of menopause hot flashes among women in the region. Also, the growing issues of urogenital complications along with vasomotor symptoms also boost the growth of the regional market significantly. The growing awareness among women regarding menopause symptoms and its treatment is also propelling the growth of the regional market.

Asia Pacific is anticipated to witness huge growth during the forecast period due to the growing number of companies offering the medication and other facilities in the menopausal hot flash sector.

Global Menopausal Hot Flashes Market: Competitive Players

Some of the significant players in the global menopausal hot flashes market are TherapeuticsMD, Inc, GlaxoSmithKline plc, Merck & Co., Inc., Hisamitsu Pharmaceutical Co., Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Allergan plc, Novo Nordisk A/S, Novartis AG, and Pfizer Inc.

Global Menopausal Hot Flashes Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Table Of Content

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

One of the major factors driving the growth of the global menopausal hot flashes market is the growing need for treatment for menopause symptoms as women are increasingly facing disturbed mental and physical health. Moreover, a significant spike in insomnia, irritability, mood swings, fatigue, anxiety, migraine, formication, and hot flashes is also propelling the demand for menopause symptom medication. Women are facing a stressful and hectic lifestyle with no scope of relaxation and peace of mind.

 

Some of the significant players in the global menopausal hot flashes market are TherapeuticsMD, Inc, GlaxoSmithKline plc, Merck & Co., Inc., Hisamitsu Pharmaceutical Co., Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Allergan plc, Novo Nordisk A/S, Novartis AG, and Pfizer Inc.

North America accounts for the largest share in the global menopausal hot flashes market due to the growing incidences of menopause hot flashes among women in the region. Also, the growing issues of urogenital complications along with vasomotor symptoms also boost the growth of the regional market significantly. The growing awareness among women regarding menopause symptoms and its treatment is also propelling the growth of the regional market.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed